Is Unicycive Therapeutics, Inc. (UNCY) a Buy, Sell, or Hold?
NASDAQ : UNCY
Unicycive Therapeutics, Inc. — Institutional Ownership
$5.39 USD
$0.39 (7.8%)
- Volume
- 1.5M
- Average Volume
- 1.22M
- Market Capitalization
- $143.91M
- P/E Ratio
- -3.22
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $8.74
- Year Low
- $3.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.81
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-30 | BlackRock, Inc. | 1.41M | 5.30% |
| 2026-05-15 | RA Capital Management, L.P. | 2.8M | 9.90% |
| 2026-02-17 | RA Capital Management, L.P. | 2.39M | 9.90% |
| 2026-02-13 | Nantahala Capital Management, LLC | 2.28M | 9.99% |
| 2026-02-10 | Octagon Capital Advisors LP | 1M | 4.70% |
| 2026-01-23 | Integrated Core Strategies (US) LLC | 1.17M | 5.50% |
| 2025-11-14 | RA Capital Management, L.P. | 1.96M | 9.90% |
| 2025-11-14 | Nantahala Capital Management, LLC | 1.86M | 9.99% |
| 2025-11-14 | Great Point Partners, LLC | 796.56K | 4.51% |
| 2025-11-14 | Vivo Opportunity Fund Holdings, L.P. | 6.1M | 9.99% |
| 2025-11-14 | Octagon Capital Advisors LP | 1M | 5.70% |
| 2025-08-14 | BIOTECHNOLOGY VALUE FUND L P | 777.31K | 5.70% |
| 2025-08-14 | Great Point Partners, LLC | 796.56K | 6.24% |
| 2025-08-14 | Nantahala Capital Management, LLC | 1.23M | 9.99% |
| 2025-08-12 | Octagon Capital Advisors LP | 1M | 7.80% |
| 2025-05-15 | Vivo Opportunity Fund Holdings, L.P. | 60.96M | 9.99% |
| 2025-05-15 | Nantahala Capital Management, LLC | 12.24M | 9.99% |
| 2025-05-15 | RA Capital Management, L.P. | 13.29M | 9.90% |
| 2025-02-14 | RA Capital Management, L.P. | 11.52M | 9.90% |
| 2025-02-14 | Great Point Partners, LLC | 11.47M | 9.99% |
| 2025-02-06 | Walleye Capital LLC | 5M | 4.82% |
| 2024-11-13 | Walleye Capital LLC | 5M | 5.30% |
| 2024-10-11 | Octagon Investments Master Fund LP | 5.56M | 5.90% |
| 2024-10-11 | Octagon Private Opportunities Fund II LP | 3M | 3.20% |
| 2024-10-11 | Octagon Capital Advisors LP | 8.56M | 9.10% |
| 2024-10-11 | Ting Jia | 8.56M | 9.10% |
| 2024-07-18 | Dr. Jeffrey R. Jay, M.D. | 8.56M | 9.99% |
| 2024-07-18 | Mr. Ortav Yehudai | 8.56M | 9.99% |
| 2024-07-18 | Great Point Partners, LLC | 8.56M | 9.99% |
| 2024-02-05 | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 2.12M | 6.10% |
| 2024-01-22 | Arsani William | 3.47M | 11.00% |
| 2024-01-22 | Logos Opportunities II GP, LLC | 3.47M | 11.00% |
| 2024-01-22 | Logos Opportunities Fund III LP | 3.47M | 11.00% |
| 2024-01-22 | Logos Global Management GP LLC | 3.47M | 11.00% |
| 2024-01-22 | Logos Global Management LP | 3.47M | 11.00% |
| 2023-07-14 | Opportunity Fund Holdings, L.P. | 59.96M | 9.99% |
| 2023-07-14 | Opportunity, LLC | 59.96M | 9.99% |
| 2023-07-06 | Peter Kolchinsky | 3.47M | 9.99% |
| 2023-07-06 | Rajeev Shah | 3.47M | 9.99% |
| 2023-07-06 | RA Capital Healthcare Fund, L.P. | 3.47M | 9.99% |
| 2023-07-06 | Biotechnology Value Fund, L.P. | 1.86M | 5.30% |
| 2023-07-06 | RA Capital Management, L.P. | 3.47M | 9.99% |
| 2022-02-14 | Nantahala Capital Management, LLC | 1.25M | 8.00% |
| 2022-02-15 | Armistice Capital, LLC | 800K | 5.10% |
| 2022-02-14 | Daniel Mack | 1.25M | 8.00% |
| 2022-02-15 | Steven Boyd | 800K | 5.10% |
| 2022-02-14 | Wilmot B. Harkey | 1.25M | 8.00% |
| 2021-09-23 | S | 812.56K | 5.60% |
| 2021-09-23 | S | 812.56K | 5.60% |
| 2021-09-23 | S | 812.56K | 5.60% |
| 2021-09-23 | S | 812.56K | 5.60% |
UNCY Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $5.77 | 15.89M | $91.67M | $29.2M | $199K | $62.67M |
| 2024-12-31 | $7.94 | 6.7M | $53.19M | $26.14M | $773K | $27.82M |
| 2023-12-31 | $8.68 | 2.45M | $21.3M | $9.7M | $811K | $12.41M |
| 2022-12-31 | $5.40 | 1.51M | $8.13M | $455K | $201K | $7.88M |
| 2021-12-31 | $20.60 | 1.5M | $30.89M | $16.58M | $335K | $14.65M |
| 2020-12-31 | $50.00 | 1.52M | $76.23M | -$ | $2.51M | $78.75M |
| 2019-12-31 | $50.00 | 1.52M | $76.23M | $15000 | $460K | $76.68M |
| 2018-12-31 | $50.00 | 1.52M | $76.23M | $25000 | $1.05M | $77.26M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4.69 | 26.92M | $126.24M | $44.18M | $671K | $82.73M |
| 2026-03-31 | $6.58 | 23.91M | $157.32M | $37.37M | $941K | $120.89M |
| 2025-12-31 | $5.77 | 19.9M | $114.81M | $29.2M | $199K | $85.81M |
| 2025-09-30 | $4.36 | 18.07M | $78.77M | $42.7M | $505K | $36.58M |
| 2025-06-30 | $4.77 | 12.3M | $58.68M | $22.33M | $476K | $36.83M |
| 2025-03-31 | $5.75 | 11.68M | $67.17M | $19.77M | $694K | $48.1M |
| 2024-12-31 | $7.94 | 7.8M | $61.9M | $26.14M | $773K | $36.53M |
| 2024-09-30 | $4.08 | 8.89M | $36.29M | $32.35M | $807K | $4.75M |
| 2024-06-30 | $5.40 | 3.79M | $20.47M | $41.78M | $634K | -$20.67M |
| 2024-03-31 | $14.10 | 3.49M | $49.23M | $48.93M | $715K | $1.01M |
| 2023-12-31 | $8.68 | 3.48M | $30.17M | $9.7M | $811K | $21.28M |
| 2023-09-30 | $8.60 | 3.26M | $28.06M | $14.34M | $866K | $14.59M |